Immuno-synergy? Neoantigen vaccines and checkpoint blockade in glioblastoma.
Publication
, Journal Article
Woroniecka, K; Fecci, PE
Published in: Neuro Oncol
September 29, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Neuro Oncol
DOI
EISSN
1523-5866
Publication Date
September 29, 2020
Volume
22
Issue
9
Start / End Page
1233 / 1234
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Immunotherapy
- Humans
- Glioblastoma
- Cancer Vaccines
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Woroniecka, K., & Fecci, P. E. (2020). Immuno-synergy? Neoantigen vaccines and checkpoint blockade in glioblastoma. Neuro Oncol, 22(9), 1233–1234. https://doi.org/10.1093/neuonc/noaa170
Woroniecka, Karolina, and Peter E. Fecci. “Immuno-synergy? Neoantigen vaccines and checkpoint blockade in glioblastoma.” Neuro Oncol 22, no. 9 (September 29, 2020): 1233–34. https://doi.org/10.1093/neuonc/noaa170.
Woroniecka K, Fecci PE. Immuno-synergy? Neoantigen vaccines and checkpoint blockade in glioblastoma. Neuro Oncol. 2020 Sep 29;22(9):1233–4.
Woroniecka, Karolina, and Peter E. Fecci. “Immuno-synergy? Neoantigen vaccines and checkpoint blockade in glioblastoma.” Neuro Oncol, vol. 22, no. 9, Sept. 2020, pp. 1233–34. Pubmed, doi:10.1093/neuonc/noaa170.
Woroniecka K, Fecci PE. Immuno-synergy? Neoantigen vaccines and checkpoint blockade in glioblastoma. Neuro Oncol. 2020 Sep 29;22(9):1233–1234.
Published In
Neuro Oncol
DOI
EISSN
1523-5866
Publication Date
September 29, 2020
Volume
22
Issue
9
Start / End Page
1233 / 1234
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Immunotherapy
- Humans
- Glioblastoma
- Cancer Vaccines
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences